Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus 1”

2,410 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,410 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02016924
What this trial is testing

Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV

Who this might be right for
Acquired Immune Deficiency Syndrome (AIDS)HIV Infections
Gilead Sciences 133
Not applicableStudy completedNCT00458562
What this trial is testing

Identifying Genes That Predict Risk of Developing Cervical Intraepithelial Neoplasia or Invasive Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Washington 1,680
Early research (Phase 1)Study completedNCT00000779
What this trial is testing

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 130
Not applicableApproved For MarketingNCT03847376
What this trial is testing

Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection

Who this might be right for
HIV
Janssen Sciences Ireland UC
Early research (Phase 1)Study completedNCT03382418
What this trial is testing

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Temporarily pausedNCT06680479
What this trial is testing

Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05527418
What this trial is testing

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Who this might be right for
Recent HIV-1 Infection
Eva Bonfill 24
Post-approval studies (Phase 4)Study completedNCT03087890
What this trial is testing

Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

Who this might be right for
HIV-1-infectionPneumocystis PneumoniaOpportunistic Infections+2 more
University of Bergen 537
Not applicableStudy completedNCT01286259
What this trial is testing

Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals

Who this might be right for
HIV-1 Infection
University of California, San Francisco 16
Early research (Phase 1)Study completedNCT01712425
What this trial is testing

Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv Candidate HIV-1 Vaccines in Recently HIV-1 Infected Individuals

Who this might be right for
HIV
IrsiCaixa 48
Testing effectiveness (Phase 2)Study completedNCT03784079
What this trial is testing

A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 34
Large-scale testing (Phase 3)Study completedNCT05896748
What this trial is testing

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 94
Large-scale testing (Phase 3)Looking for participantsNCT07044297
What this trial is testing

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 4,390
Not applicableUnknownNCT00797381
What this trial is testing

Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia

Who this might be right for
HIV InfectionHemophilia A
Shanghai Public Health Clinical Center 100
Large-scale testing (Phase 3)Study completedNCT01440569
What this trial is testing

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 314
Early research (Phase 1)Study completedNCT00002353
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects

Who this might be right for
HIV Infections
United Biomedical
Not applicableActive Not RecruitingNCT06451341
What this trial is testing

IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

Who this might be right for
HIV
University of Nebraska 55
Testing effectiveness (Phase 2)Study completedNCT00476853
What this trial is testing

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Who this might be right for
HIV InfectionsTuberculosis
The HIV Netherlands Australia Thailand Research Collaboration 42
Not applicableStudy completedNCT00001137
What this trial is testing

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 5,982
Early research (Phase 1)Study completedNCT00000957
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Load More Results